225 related articles for article (PubMed ID: 12384553)
1. An antisense oligonucleotide targeted to human Ku86 messenger RNA sensitizes M059K malignant glioma cells to ionizing radiation, bleomycin, and etoposide but not DNA cross-linking agents.
Belenkov AI; Paiement JP; Panasci LC; Monia BP; Chow TY
Cancer Res; 2002 Oct; 62(20):5888-96. PubMed ID: 12384553
[TBL] [Abstract][Full Text] [Related]
2. Polyethyleneimine grafted with pluronic P85 enhances Ku86 antisense delivery and the ionizing radiation treatment efficacy in vivo.
Belenkov AI; Alakhov VY; Kabanov AV; Vinogradov SV; Panasci LC; Monia BP; Chow TY
Gene Ther; 2004 Nov; 11(22):1665-72. PubMed ID: 15470482
[TBL] [Abstract][Full Text] [Related]
3. Transfer of Ku86 RNA antisense decreases the radioresistance of human fibroblasts.
Marangoni E; Le Romancer M; Foray N; Muller C; Douc-Rasy S; Vaganay S; Abdulkarim B; Barrois M; Calsou P; Bernier J; Salles B; Bourhis J
Cancer Gene Ther; 2000 Feb; 7(2):339-46. PubMed ID: 10770645
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy.
Daido S; Yamamoto A; Fujiwara K; Sawaya R; Kondo S; Kondo Y
Cancer Res; 2005 May; 65(10):4368-75. PubMed ID: 15899829
[TBL] [Abstract][Full Text] [Related]
5. Ku86 variant expression and function in multiple myeloma cells is associated with increased sensitivity to DNA damage.
Tai YT; Teoh G; Lin B; Davies FE; Chauhan D; Treon SP; Raje N; Hideshima T; Shima Y; Podar K; Anderson KC
J Immunol; 2000 Dec; 165(11):6347-55. PubMed ID: 11086072
[TBL] [Abstract][Full Text] [Related]
6. Different G2/M accumulation in M059J and M059K cells after exposure to DNA double-strand break-inducing agents.
Holgersson A; Heiden T; Castro J; Edgren MR; Lewensohn R; Meijer AE
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):915-21. PubMed ID: 15708275
[TBL] [Abstract][Full Text] [Related]
7. Human normal peripheral blood B-lymphocytes are deficient in DNA-dependent protein kinase activity due to the expression of a variant form of the Ku86 protein.
Muller C; Dusseau C; Calsou P; Salles B
Oncogene; 1998 Mar; 16(12):1553-60. PubMed ID: 9569022
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated heat-activated antisense Ku70 expression radiosensitizes tumor cells in vitro and in vivo.
Li GC; He F; Shao X; Urano M; Shen L; Kim D; Borrelli M; Leibel SA; Gutin PH; Ling CC
Cancer Res; 2003 Jun; 63(12):3268-74. PubMed ID: 12810658
[TBL] [Abstract][Full Text] [Related]
9. Restoration of X-ray and etoposide resistance, Ku-end binding activity and V(D) J recombination to the Chinese hamster sxi-3 mutant by a hamster Ku86 cDNA.
He DM; Lee SE; Hendrickson EA
Mutat Res; 1996 May; 363(1):43-56. PubMed ID: 8632777
[TBL] [Abstract][Full Text] [Related]
10. Ku affects the CHK1-dependent G(2) checkpoint after ionizing radiation.
Wang X; Li GC; Iliakis G; Wang Y
Cancer Res; 2002 Nov; 62(21):6031-4. PubMed ID: 12414624
[TBL] [Abstract][Full Text] [Related]
11. Analysis of variable (diversity) joining recombination in DNAdependent protein kinase (DNA-PK)-deficient mice reveals DNA-PK-independent pathways for both signal and coding joint formation.
Bogue MA; Jhappan C; Roth DB
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15559-64. PubMed ID: 9861008
[TBL] [Abstract][Full Text] [Related]
12. Effect of Ku86 and DNA-PKcs deficiency on non-homologous end-joining and homologous recombination using a transient transfection assay.
Secretan MB; Scuric Z; Oshima J; Bishop AJ; Howlett NG; Yau D; Schiestl RH
Mutat Res; 2004 Oct; 554(1-2):351-64. PubMed ID: 15450431
[TBL] [Abstract][Full Text] [Related]
13. Ku86 modulates DNA topoisomerase I-mediated radiosensitization, but not cytotoxicity, in mammalian cells.
Shih SJ; Erbele T; Chen AY
Cancer Res; 2005 Oct; 65(20):9194-9. PubMed ID: 16230379
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a Ku86 variant protein that results in altered DNA binding and diminished DNA-dependent protein kinase activity.
Han Z; Johnston C; Reeves WH; Carter T; Wyche JH; Hendrickson EA
J Biol Chem; 1996 Jun; 271(24):14098-104. PubMed ID: 8662896
[TBL] [Abstract][Full Text] [Related]
15. Activities of DNA-PK and Ku86, but not Ku70, may predict sensitivity to cisplatin in human gliomas.
Shao CJ; Fu J; Shi HL; Mu YG; Chen ZP
J Neurooncol; 2008 Aug; 89(1):27-35. PubMed ID: 18415044
[TBL] [Abstract][Full Text] [Related]
16. Ku86 is essential in human somatic cells.
Li G; Nelsen C; Hendrickson EA
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):832-7. PubMed ID: 11792868
[TBL] [Abstract][Full Text] [Related]
17. Cross-resistance to ionizing radiation in a murine leukemic cell line resistant to cis-dichlorodiammineplatinum(II): role of Ku autoantigen.
Frit P; Canitrot Y; Muller C; Foray N; Calsou P; Marangoni E; Bourhis J; Salles B
Mol Pharmacol; 1999 Jul; 56(1):141-6. PubMed ID: 10385694
[TBL] [Abstract][Full Text] [Related]
18. Deficiency in the catalytic subunit of DNA-dependent protein kinase causes down-regulation of ATM.
Peng Y; Woods RG; Beamish H; Ye R; Lees-Miller SP; Lavin MF; Bedford JS
Cancer Res; 2005 Mar; 65(5):1670-7. PubMed ID: 15753361
[TBL] [Abstract][Full Text] [Related]
19. The activity of the DNA-dependent protein kinase (DNA-PK) complex is determinant in the cellular response to nitrogen mustards.
Muller C; Calsou P; Salles B
Biochimie; 2000 Jan; 82(1):25-8. PubMed ID: 10717383
[TBL] [Abstract][Full Text] [Related]
20. Human colon carcinoma cell-line HCT116 transfected by antisense cDNA as a tool to study the Ku86 involvement in cell proliferation.
Sadji Z; Le Romancer M; Lewin MJ; Reyl-Desmars F
Cell Signal; 2000 Dec; 12(11-12):745-50. PubMed ID: 11152960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
